Lymphopenia in COVID‐19: Therapeutic opportunities
Cell Biology International2020Vol. 44(9), pp. 1792–1797
Citations Over TimeTop 10% of 2020 papers
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is uncontrollably spread all over the world. The host immune responses strongly try to confront it with all the potential cells and cytokines. With chronically condition of SARS-CoV-2, natural killer cells and T cells become exhausted and decreasing their count leads to lymphopenia. Inability to eradicate the infected organ makes hyperinitiation of the immune system, which releases the excessive inflammatory cytokines to compensate the exhausted one as well as the low lymphocytes counts; it consequently leads to the cytokine storm syndrome. These mechanisms and the potential therapeutic targeting are discussed in this paper.
Related Papers
- → Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases(2021)95 cited
- → An enlightening role for cytokine storm in coronavirus infection(2020)44 cited
- Cytokine and cytokine storm(2020)
- Cytokine and cytokine storm after SARS-CoV-2 infection(2020)
- → Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy(2022)